Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.01 -0.14 (-3.37%)
At close: Sep 30, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Other Non-Current Liabilities (2022 - 2026)

Updated

Adial Pharmaceuticals (ADIL) posted Other Non-Current Liabilities of $23.81 million for Q2 2026.

Analysis

Adial Pharmaceuticals (ADIL) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

At the end of FY2022, Adial Pharmaceuticals' Other Non-Current Liabilities came in at $665,444.

  • The Q2 2026 figure stands as the lowest quarterly Other Non-Current Liabilities since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Adial Pharmaceuticals 18.53 Mn 18.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.81 Mn
Dec 31, 2022 665,444.00
API Access

Adial Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ADIL&period=max&api_key=YOUR_API_KEY